Oliver Schwartz
Rudolf Buchheim Str. 8
Giessen, HE 35392, Germany
Giessen, HE 35392, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland - part II - expert based recommendations for surveillance and management of side-effects.
Journal: Journal of neuromuscular diseases
Published: August 27, 2026
Delphi consensus on gene therapy of spinal muscular atrophy with onasemnogene abeparvovec in Germany, Austria and Switzerland-part I-systematic literature review and existing evidence.
Journal: Journal of neuromuscular diseases
Published: November 24, 2025
Concerns About Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy-Reply.
Journal: JAMA pediatrics
Published: July 29, 2024
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.
Journal: The Lancet regional health. Europe
Published: June 28, 2024
Impaired Neurodevelopment in Children with 5q-SMA - 2 Years After Newborn Screening.
Journal: Journal of neuromuscular diseases
Published: November 06, 2023
5qSMA: standardised retrospective natural history assessment in 268 patients with four copies of SMN2.
Journal: Journal of neurology
Published: October 30, 2023
Newbornscreening SMA - From Pilot Project to Nationwide Screening in Germany.
Journal: Journal of neuromuscular diseases
Published: December 04, 2022
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany.
Journal: Orphanet journal of rare diseases
Published: October 26, 2022
Pathogenic variants in CLXN encoding the outer dynein arm docking-associated calcium-binding protein calaxin cause primary ciliary dyskinesia.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: October 20, 2022
Parental Burden and Quality of Life in 5q-SMA Diagnosed by Newborn Screening.
Journal: Children (Basel, Switzerland)
Published: October 16, 2022
Newborn Screening for SMA - Can a Wait-and-See Strategy be Responsibly Justified in Patients With Four SMN2 Copies?
Journal: Journal of neuromuscular diseases
Published: July 18, 2022
Last Updated: 09/26/2026